Lignokent

Epinephrine and Lidocaine Hydrochloride, the active ingredient in Lignokent, is a local anesthetic and vasoconstrictor presented as a solution for infiltration use. It provides rapid, localized numbness for dental procedures and minor surgical or diagnostic interventions in adult patients.

GNH USA supplies Lignokent as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring consistent quality and regulatory compliance across markets. The company provides reliable logistics, documentation support, and responsive customer service to meet the needs of healthcare providers in diverse regions.

Lignokent, a combination of epinephrine and lidocaine, provides local anesthesia by acting on peripheral nerve conduction and vascular tone.

Dental procedures: provides rapid, profound anesthesia for extractions, restorations, and periodontal work. Minor surgical interventions: enables infiltration anesthesia for skin biopsies, suturing, and minor excisions. Diagnostic procedures: facilitates patient comfort during minor invasive diagnostic techniques such as catheter insertions.

Lignokent may cause a range of adverse reactions, most of which are related to its local anesthetic or vasoconstrictive components.

Common Side Effects: - Transient pain or burning at the injection site. - Mild swelling or bruising. - Temporary numbness lasting beyond the procedure. - Tachycardia or mild palpitations.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with rash, swelling, or breathing difficulty. - Cardiac arrhythmias or myocardial ischemia. - Seizures due to systemic lidocaine toxicity.

When using Lignokent, several precautions should be observed to ensure patient safety and product integrity. - Assess patient history: verify allergies to lidocaine, epinephrine, or related compounds. - Monitor cardiovascular status: observe heart rate and blood pressure during and after injection. - Limit dosage: adhere to recommended maximum lidocaine dose, especially in pediatric or compromised patients. - Avoid intravascular injection: aspirate before administering to reduce systemic exposure. - Use with caution in patients on beta‑blockers or MAO inhibitors, as epinephrine effects may be altered. - Store at room temperature: keep below 25°C, protect from light and moisture, and retain in original container.

Lignokent can interact with other medications, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Non‑selective beta‑blockers: may potentiate epinephrine‑induced hypertension and tachycardia. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis with epinephrine. - Class I antiarrhythmic agents (e.g., quinidine): may exacerbate lidocaine toxicity.

Moderate Interactions (Monitor Closely): - Other local anesthetics: cumulative lidocaine dose may exceed safe limits. - Tricyclic antidepressants: can lower seizure threshold when combined with lidocaine. - Diuretics (e.g., furosemide): may enhance systemic absorption of lidocaine.